XML 68 R62.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2021
Dec. 31, 2023
Stock-Based Compensation (Details) [Line Items]        
Issuance of common stock 11,408,818 133,922    
Unrecognized compensation cost related to nonvested stock options grant (in Dollars) $ 2,700      
Weighted-average over period 10 months 24 days      
Stock-based compensation expense $ 200 $ 4,500    
Long-term liability $ 384,229     $ 381,436
Third anniversary [Member]        
Stock-Based Compensation (Details) [Line Items]        
Share prices of our common stock $ 24.2      
Performance Based Restricted Stock Units [Member]        
Stock-Based Compensation (Details) [Line Items]        
Vesting description the vesting dates, which we anticipate will be in March 2025 and February 2026, for awards granted in 2022 and 2023, respectively. Our performance did not meet the required conditions for vesting for the PRSUs that were scheduled to vest in February 2024 and accordingly they expired unvested during the three months ended March 31, 2024. We are currently assuming 100% attainment of our 2025 metrics and 0% attainment of our 2024 metrics. All of the PRSUs granted in 2022 and 2023 remained outstanding at March 31, 2024.      
Liability $ 100      
Recognized related compensation expense $ 0 $ 300    
Performance Based Restricted Stock Units [Member] | Maximum [Member]        
Stock-Based Compensation (Details) [Line Items]        
Vesting percentage 100.00%      
Performance Based Restricted Stock Units [Member] | Minimum [Member]        
Stock-Based Compensation (Details) [Line Items]        
Vesting percentage 50.00%      
Stock Option        
Stock-Based Compensation (Details) [Line Items]        
Weighted average grant-date fair value of options granted (in Dollars per share)   $ 1.17    
Stock options   2,571,737    
Number of Shares, Granted 0 204,254    
Liability $ 400      
Long-term liability $ 500     100
Market Based Restricted Shares [Member]        
Stock-Based Compensation (Details) [Line Items]        
Restricted stock shares 754,818      
Number of Shares, Granted 1,517,840   1,517,840  
Stock-based compensation expense   $ 4,700    
Liability $ 300     $ 300
Market Based Restricted Shares [Member] | Maximum [Member]        
Stock-Based Compensation (Details) [Line Items]        
Stock-based compensation expense $ 400 $ 600    
Cash Settled Options [Member]        
Stock-Based Compensation (Details) [Line Items]        
Number of Shares, Granted   1,050,000    
2020 ESPP [Member]        
Stock-Based Compensation (Details) [Line Items]        
Issuance of common stock 136,530      
Shares issued from inception 401,748      
ESPP plan, percentage of stock discount 15.00%      
Share-based compensation, authorized shares 2,571,737      
2020 Incentive Plan [Member]        
Stock-Based Compensation (Details) [Line Items]        
Share-based compensation, remained authorized for Issuance 4,519,719     4,823,519